Preclinical proof of concept for STX-1200: potent LPA editing and Apo(a) knockdown via CasX-based gene editing

1 September 2025 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Molecular networks and emerging therapeutics in cardiac pathophysiology Gene Therapy, Cell Therapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology